Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Seed phrases unlock access to your funds. This guide explains why sharing or exposing your seed phrase is dangerous and how to store it securely.
27,349 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
As AI workloads surge, Celestica could play a pivotal role in data-center hardware. This guide breaks down the busine...
A leading tech investor envisions a future where AI-enabled labor trims traditional work yet expands access to essent...
This article offers a fresh, investor-focused look at american outdoor brands (aout) earnings. It breaks down revenue...
This deep-dive breaks down accelerant (arx) 2026 earnings, translating the Q1 transcript into actionable takeaways. L...
When a tech titan steps into AI, markets listen. This article explains why apple just joined revolution could reshape...
Archer Aviation teams with defense innovator Anduril to roll out a new autonomous VTOL platform, blending commercial ...
Mind tech (mind) 2027 is shaping a new era for investors who seek durable growth in neurotech and digital mental heal...
Could Monero surpass Cardano by 2028? This article lays out the pathways, risks, and strategies for investors trackin...
Two clinical-stage biotech names, two distinct paths to value. This guide breaks down Dyne Therapeutics and Viking Th...
The funded-account scene for crypto traders has split into two distinct paths in 2026: crypto-native firms built for ...
IBM is quietly reshaping its story with a serious quantum strategy, strong enterprise demand, and a durable dividend....